| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269570 | HPB | 2012 | 9 Pages |
Abstract
The results of the present study suggest that the routine use of TachoSil® after a liver resection does not reduce the overall complication rate compared with Surgicel® application. However, TachoSil® may be beneficial in a major hepatectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Thomas Zacharias, Nelio Ferreira,